Display options
Share it on

Int J Oncol. 1993 Jun;2(6):1003-8. doi: 10.3892/ijo.2.6.1003.

Influence of insulin-like growth factor-I antiserum to proliferation of T-cell receptor-activated human T-lymphocytes.

International journal of oncology

K Hartmann, R Teckentrup, D Nixdorf, S Meuer, V Papa, U Heinrich

Affiliations

  1. DEPT PEDIAT,FRANKFURT,GERMANY. UNIV CATANIA,DEPT ENDOCRINOL,I-95124 CATANIA,ITALY. UNIV HEIDELBERG,DEPT PEDIAT ENDOCRINOL,W-6900 HEIDELBERG,GERMANY. UNIV HEIDELBERG,CANC RES CTR,W-6900 HEIDELBERG,GERMANY.

PMID: 21573660 DOI: 10.3892/ijo.2.6.1003

Abstract

We have previously reported that Insulin-like growth factor (IGF-I) is a cellular growth factor of human transformed T-lymphocytes. To evaluate the role of IGF-I for nontransformed T-cells we investigated synthesis of IGF-I and the influence of an IGF-I antiserum, UBK487, during proliferation process. IGF-I is synthesized by B-lymphocytes and monocytes during proliferation. Via the T-cell receptor (CD3 subunit) induced proliferation of resting T-cells was inhibited by addition of UBK487. The addition of monocytes to the resting T-cell fraction reversed the UBK487 effect. Using UBK487, a 12 kDa protein could be immunoprecipitated from unstimulated or PHA stimulated T-cells whereas a 36 kDa protein could be immunoprecipitated from OKT3 stimulated T-cells.

Publication Types